Early interventions to detect potential drug–drug interactions on patient eligibility for phase 1 clinical trials. (December 2016) - Azaro, A.; Ghiglione, L.; Valdivia, C.; Munné, M.; Renedo, B.; Sabaté, N.; Alcalde, M.; Braña, I.; Hierro, C.; Martin-Liberal, J.; Ochoa de Olza, M.; Argiles Martínez, G.; et al.